Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.003 per share
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
110,598,225
-
Share change
-
-4,595,712
-
Total reported value
-
$250,098,919
-
Put/Call ratio
-
67%
-
Price per share
-
$2.25
-
Number of holders
-
87
-
Value change
-
-$12,622,883
-
Number of buys
-
39
-
Number of sells
-
35
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q1 2025
As of 31 Mar 2025,
Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,598,225 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Rubric Capital Management LP, MANGROVE PARTNERS IM, LLC, Frazier Life Sciences Management, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Rock Springs Capital Management LP, ALKEON CAPITAL MANAGEMENT LLC, 683 Capital Management, LLC, Clearline Capital LP, and Tejara Capital Ltd.
This page lists
87
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.